Klencke Barbara 4
4 · TScan Therapeutics, Inc. · Filed Apr 10, 2023
Insider Transaction Report
Form 4
Klencke Barbara
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-04-06+9,146→ 9,146 totalExercise: $2.20Exp: 2033-04-05→ Voting Common Stock (9,146 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in thirty-six equal monthly installments following April 6, 2023, subject to the Reporting Person's continued service at such time.